Clinical Trial Update: Rate Control in Atrial Fibrillation [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial assessing rate control in atrial fibrillation conducted by Tehran University of Medical Sciences has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Snippet

Sponsor: Tehran University of Medical Sciences | Conditions: Rapid Ventricular Response Atrial Fibrillation | Phase 4 | Status: COMPLETED